Inventor · disambiguated record
Cameron J. Turtle
Also filed as: TURTLE CAMERON J · TURTLE CAMERON JOHN
5 granted patents·9 pending applications·7 citations·filing 2003–2025
72Inventor score
Files withFRED HUTCHINSON CANCER CENTER4JUNO THERAPEUTICS INC4HUTCHINSON FRED CANCER RES3NEKTAR THERAPEUTICS1ORDER SISTERS OF MERCY QUEENSL1
Top patents by PatentIndex Score
14 records- 0185US10653756B2Identification of CD8+ T cells that are CD161hi and/or IL18R(α)hi and have rapid drug efflux capacityHUTCHINSON FRED CANCER RES·Filed 2018·Granted May 19, 2020·2 cites·15 claims
- 0283US11815514B2Methods and compositions related to toxicity associated with cell therapyJUNO THERAPEUTICS INC·Filed 2016·Granted Nov 14, 2023·2 cites·31 claims
- 0372US2024103012A1Methods and compositions related to toxicity associated with cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0470US9090875B2Identifcation of CD8+ T cells that are CD161hi and/or IL18Rαhi and have rapid drug efflux capacityTURTLE CAMERON J·Filed 2009·Granted Jul 28, 2015·2 cites·14 claims
- 0569US9931384B2Identification of CD8+ T cells that are CD161hi and/or IL18Rαhi and have rapid drug efflux capacityHUTCHINSON FRED CANCER RES·Filed 2015·Granted Apr 3, 2018·1 cites·20 claims
- 0666US2023003733A1Biomarkers and uses thereof for selecting immunotherapy interventionFRED HUTCHINSON CANCER CENTER·Filed 2022·Application pending·0 cites
- 0758US2025197471A1Methods for the treatment of b cell malignancies using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0857US11397183B2Biomarkers and uses thereof for selecting immunotherapy interventionFRED HUTCHINSON CANCER CENTER·Filed 2018·Granted Jul 26, 2022·0 cites·21 claims
- 0947US2021223248A1Biomarkers, uses thereof for selecting immunotherapy intervention, and immunotherapy methodsHUTCHINSON FRED CANCER RES·Filed 2019·Application pending·0 cites
- 1046US2009098090A1Vitro immunizationORDER SISTERS OF MERCY QUEENSL·Filed 2003·Application pending·0 cites
- 1145US2023158164A1Method for enhancing cellular immunotherapyNEKTAR THERAPEUTICS·Filed 2020·Application pending·0 cites
- 1245US2020016199A1Methods for the treatment of b cell malignancies using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1345US2023151094A1Chimeric antigen receptors targeting cd33FRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
- 1443US2023218669A1Augmenting antigen-negative cell death in antigen-targeted immunotherapiesFRED HUTCHINSON CANCER CENTER·Filed 2021·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →